AVASTIN Safety Questions, AVASTIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about AVASTIN. Our extensive database of AVASTIN adverse events and AVASTIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about AVASTIN
AVASTIN Safety Reports
Total AVASTIN reports: 1647.AVASTIN FDA safety alerts: 2004 2005 2006 2007 .
Reported deaths: 237 Reported hospitalizations: 894.
Take AVASTIN Side Effects Survey or Share Your AVASTIN Story. AVASTIN Usage.
Showing 1-75 of 1647 Next >
Health Professional from UNITED STATES reported AVASTIN problem on Jan 22, 2007. Male patient, 63 years of age, weighting 189.0 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood pressure increased, dyspnoea, hypersomnia, mental status changes, musculoskeletal chest pain, platelet count decreased, pulmonary artery thrombosis, pulmonary embolism. AVASTIN dosage: 868MG EVERY 2 WEEKS IV. During the same period patient was treated with ALDESLEUKIN, LEVOFLOXACIN, RHINOCORT. Patient was hospitalized. Patient recovered.AVASTIN problem was reported by a Pharmacist from UNITED STATES on Jan 22, 2007. Male patient, 57 years of age, weighting 216.1 lb, was diagnosed with metastatic malignant melanoma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hypertensive emergency. AVASTIN dosage: unknown. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported AVASTIN problem on Jan 03, 2007. Female patient, 52 years of age, weighting 123.5 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disease progression, intestinal obstruction. AVASTIN dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, CELEBREX, NEXIUM, TRAMADOL, OXYCODONE, PANADOL, MORPHINE, OXYCONTIN. Patient was hospitalized. Patient died on 10/29/2006.
AVASTIN problem was reported by a Physician from AUSTRALIA on Jan 18, 2007. Female patient, 52 years of age, was diagnosed with gastrointestinal carcinoma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome, pulmonary haemorrhage. AVASTIN dosage: unknown. Patient recovered.
Physician from HONG KONG reported AVASTIN problem on Jan 05, 2007. Female patient, 47 years of age, weighting 102.7 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, arrhythmia, ascites, blood albumin decreased, blood potassium decreased, disease progression, gastrointestinal perforation, haemoglobin decreased. AVASTIN dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, DOLOGESIC, METHADONE, PROTHIADEN, DIAMICRON. Patient was hospitalized. Patient died on 07/31/2006.
AVASTIN problem was reported by a Consumer or non-health professional from CANADA on Jan 05, 2007. Female patient, 57 years of age, was treated with AVASTIN. AVASTIN dosage: unknown. Patient died on 12/30/2006.
Consumer or non-health professional from UNITED STATES reported AVASTIN problem on Jan 08, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abscess intestinal, colitis, fatigue, stomatitis. AVASTIN dosage: 1250 MG, UNK, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, DEXAMETHASONE, APREPITANT, ASPIRIN, ATORVASTATIN, EZETIMIBE, FOLIC ACID. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Pharmacist from UNITED STATES on Jan 18, 2007. Female patient, 64 years of age, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, interstitial lung disease. AVASTIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 09, 2007. Male patient, 57 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dehydration, diarrhoea, haematocrit decreased, hypoglycaemia, impaired healing, oral intake reduced, skin ulcer. AVASTIN dosage: 1310 MG,. During the same period patient was treated with PROLEUKIN, ATENOLOL, ACIPHEX, GLYBURIDE, NORVASC, LASIX, LORAZEPAM, BENADRYL. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, blood pressure inadequately controlled, cerebrovascular accident. AVASTIN dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported AVASTIN problem on Jan 24, 2007. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, inflammation, iritis. AVASTIN dosage: 2.5 MG. Patient recovered.
AVASTIN problem was reported by a Physician from UNITED STATES on Jan 24, 2007. Male patient, 84 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: iridocyclitis, iritis. AVASTIN dosage: OPTHALMIC, INJECTION 1.25MG. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 10, 2007. Male patient, 70 years of age, weighting 178.1 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hypotension, malaise, necrotising fasciitis, rectal abscess, sepsis. AVASTIN dosage: unknown. During the same period patient was treated with OXALIPLATIN, XELODA, VICODIN, PRILOSEC, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Health Professional from UNITED STATES on Jan 12, 2007. Male patient, 78 years of age, weighting 175.9 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cervical spinal stenosis, extensor plantar response, lumbar spinal stenosis, muscular weakness, paraesthesia, spinal cord disorder, urinary retention. AVASTIN dosage: 630 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 08, 2007. Male patient, 59 years of age, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, pulse absent. AVASTIN dosage: 7.5 MG MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CAPECITABINE. Patient died on 12/21/2006.
AVASTIN problem was reported by a Health Professional from UNITED STATES on Jan 19, 2007. Female patient, 36 years of age, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ascites, dacryostenosis acquired, embolism, fluid retention, lactic acidosis, musculoskeletal disorder, oedema peripheral, pain, pleural effusion. AVASTIN dosage: unknown. During the same period patient was treated with HERCEPTIN, TAXOTERE, DEXAMETHASONE. Patient recovered.
Physician from FRANCE reported AVASTIN problem on Jan 09, 2007. Male patient, 75 years of age, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cerebral disorder, haemangioma, vertigo. AVASTIN dosage: 5 MG/KG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM. Patient recovered.
AVASTIN problem was reported by a Physician from CANADA on Jan 08, 2007. Male patient, 60 years of age, weighting 197.1 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. AVASTIN dosage: 650 MG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, VITAMIN, ASCORBIC ACID. Patient recovered.
Physician from FRANCE reported AVASTIN problem on Jan 23, 2007. Male patient, 64 years of age, weighting 165.3 lb, was diagnosed with colorectal cancer, colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: aplasia. AVASTIN dosage: 562.5 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, AVLOCARDYL, IRINOTECAN, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Jan 11, 2007. Male patient, 67 years of age, weighting 234.1 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, back pain, chest pain, flushing, hypertension, stridor. AVASTIN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, CANDESARTAN, INADAPAMIDE, FLUOROURACIL, ASPIRIN, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported AVASTIN problem on Jan 11, 2007. Female patient, 74 years of age, weighting 154.3 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: palmar-plantar erythrodysaesthesia syndrome. AVASTIN dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, PANADOL, MITOMYCIN. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from UNITED STATES on Jan 16, 2007. Male patient, 77 years of age, weighting 171.1 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood bicarbonate decreased, blood creatine phosphokinase increased, blood creatinine increased, blood lactic acid increased, blood ph decreased, blood urea increased, fatigue, haematocrit decreased. AVASTIN dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, VYTORIN, MEDROL, NASACORT, VITAMIN D, ZYRTEC, ASPIRIN. Patient was hospitalized. Patient died on 11/21/2006.
Physician from UNITED STATES reported AVASTIN problem on Jan 16, 2007. Female patient, 73 years of age, was diagnosed with ovarian cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain, blood potassium increased, blood sodium decreased, chest pain, condition aggravated, disease progression, dysuria. AVASTIN dosage: 660 MG, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Health Professional from UNITED STATES on Jan 22, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, radiation oesophagitis, weight decreased. AVASTIN dosage: 10 MG/KG. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported AVASTIN problem on Jan 23, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: dehydration, nausea, vomiting. AVASTIN dosage: 1218 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from GERMANY on Jan 11, 2007. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: haemolysis. AVASTIN dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Physician from DENMARK reported AVASTIN problem on Jan 12, 2007. Female patient, 58 years of age, was diagnosed with glioblastoma multiforme and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: fatigue, hemiparesis, lacunar infarction. AVASTIN dosage: 350 MG, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CETUXIMAB, ATROPIN, TAVEGYL, CENTYL, PERINDOPRIL ERBUMINE. Patient recovered.
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Jan 11, 2007. Male patient, 66 years of age, weighting 173.3 lb, was diagnosed with colon cancer, hypertension, hypercholesterolaemia and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, haemoptysis, renal failure. AVASTIN dosage: 590 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, VALSARTAN, AMLODIPINE BESYLATE, DOXAZOSIN MESYLATE, ATENOLOL, ASPIRIN, SIMVASTATIN, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported AVASTIN problem on Jan 19, 2007. Male patient, 63 years of age, weighting 220.9 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: exfoliative rash. AVASTIN dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN. Patient recovered.
AVASTIN problem was reported by a Health Professional from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Jan 27, 2007. Male patient, 69 years of age, weighting 140.0 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anorexia, chest pain. AVASTIN dosage: 480 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, AMLODIPINE BESYLATE, LORAZEPAM, RANITIDINE, ONDANSETRON, MAGNESIUM OXIDE, NITROGLYCERIN. Patient died.
Physician from GERMANY reported AVASTIN problem on Jan 27, 2007. Female patient, 62 years of age, weighting 143.3 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: psoas abscess. AVASTIN dosage: 330 MG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Health Professional from GERMANY on Jan 27, 2007. Female patient, 67 years of age, weighting 154.3 lb, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. AVASTIN dosage: 548 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient recovered.
Physician from GREECE reported AVASTIN problem on Jan 27, 2007. Male patient, 73 years of age, weighting 184.1 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: haematocrit increased, haemoglobin increased. AVASTIN dosage: 400 MG, 2/MONTH, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN. Patient recovered.
AVASTIN problem was reported by a Physician from FRANCE on Jan 27, 2007. Male patient, 73 years of age, weighting 185.2 lb, was diagnosed with hepatic neoplasm malignant and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, hypertension, mass. AVASTIN dosage: 840 MG, Q2W, INTRAVENOUS. During the same period patient was treated with PULMICORT, SILOMAT, DOMPERIDONE. Patient was hospitalized. Patient recovered.
Physician from NETHERLANDS reported AVASTIN problem on Jan 27, 2007. Female patient, 57 years of age, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, pyrexia. AVASTIN dosage: 512 MG, QD, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from NETHERLANDS on Jan 27, 2007. Female patient, 66 years of age, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, oral intake reduced, vomiting. AVASTIN dosage: 450 MG, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, NEXIUM, PYRIDOXINE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Health Professional from CANADA reported AVASTIN problem on Jan 15, 2007. Female patient, 57 years of age, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, chest discomfort. AVASTIN dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from FRANCE on Jan 27, 2007. Male patient, 78 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anterograde amnesia. AVASTIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN. Patient recovered.
Health Professional from FRANCE reported AVASTIN problem on Jan 11, 2007. Male patient, 52 years of age, weighting 147.7 lb, was diagnosed with neoplasm malignant and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholestasis, condition aggravated, cytolytic hepatitis, hepatitis b. AVASTIN dosage: unknown. During the same period patient was treated with KYTRIL, CARBOPLATIN, TAXOL, RANITIDINE. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from AUSTRALIA on Jan 11, 2007. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anal fissure. AVASTIN dosage: 360 MG, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, TICLOPIDINE, TEVETEN, RAMIPRIL, PANTOPRAZOLE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 27, 2007. Female patient, 66 years of age, weighting 166.0 lb, was diagnosed with breast cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, palmar-plantar erythrodysaesthesia syndrome. AVASTIN dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ABRAXANE, DOXIL. Patient recovered.
AVASTIN problem was reported by a Health Professional from FRANCE on Jan 27, 2007. Female patient, 65 years of age, weighting 125.7 lb, was diagnosed with neoplasm malignant and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cholecystitis infective, gangrene. AVASTIN dosage: 285 MG, INTRAVENOUS. During the same period patient was treated with ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 19, 2007. Female patient, 36 years of age, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ascites, dacryostenosis acquired, musculoskeletal disorder, pain, peripheral embolism, pleural effusion, pulmonary embolism, white blood cell count increased. AVASTIN dosage: unknown. During the same period patient was treated with HERCEPTIN, TAXOTERE, DEXAMETHASONE. Patient recovered.
AVASTIN problem was reported by a Health Professional from UNITED STATES on Jan 27, 2007. Male patient, 58 years of age, weighting 159.8 lb, was diagnosed with adenocarcinoma pancreas and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, oesophageal candidiasis, oesophagitis, vomiting. AVASTIN dosage: 720 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 23, 2007. Female patient, 60 years of age, weighting 94.14 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cachexia, weight decreased. AVASTIN dosage: 735 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from AUSTRALIA on Jan 16, 2007. Female patient, 74 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: fall, infection, joint injury, soft tissue injury. AVASTIN dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, MITOMYCIN, TAMBOCOR, ACETAMINOPHEN. Patient was hospitalized. Patient died on 12/11/2006.
Health Professional from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF reported AVASTIN problem on Jan 09, 2007. Male patient, 69 years of age, weighting 140.0 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anorexia, chest pain, myocardial ischaemia. AVASTIN dosage: 480 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, AMLODIPINE BESYLATE, LORAZEPAM, RANITIDINE, ONDANSETRON, MAGNESIUM OXIDE, NITROGLYCERIN. Patient died.
AVASTIN problem was reported by a Physician from GERMANY on Jan 27, 2007. Male patient, 75 years of age, weighting 145.5 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anorexia, colorectal cancer, deep vein thrombosis, dehydration, erosive duodenitis, hypovolaemic shock, malignant neoplasm progression, oesophageal ulcer haemorrhage, oesophagitis ulcerative. AVASTIN dosage: 500 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient died on 04/12/2006.
Physician from CANADA reported AVASTIN problem on Jan 27, 2007. Male patient, 78 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: pneumonia. AVASTIN dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, DECADRON, ZOFRAN. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from FRANCE on Jan 27, 2007. Female patient, 52 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, convulsion, encephalitis. AVASTIN dosage: unknown. Patient recovered.
Physician from SWITZERLAND reported AVASTIN problem on Jan 27, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, agitation, constipation, cough, cyanosis, dyspepsia, dyspnoea, fall. AVASTIN dosage: 1380 MG, QD, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, IPRATROPIUM, ASPIRIN, RAMIPRIL, ADALAT, DAFALGAN, PANTOPRAZOLE, HEPARIN. Patient was hospitalized. Patient died on 12/11/2006.
AVASTIN problem was reported by a Physician from NEW ZEALAND on Jan 27, 2007. Male patient, 68 years of age, weighting 147.0 lb, was diagnosed with colorectal cancer, colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: confusional state, gastric perforation, somnolence, wound dehiscence. AVASTIN dosage: 325 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, METOPROLOL TARTRATE, BENDROFLUAZIDE, ALLOPURINOL, LOPERAMIDE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported AVASTIN problem on Jan 27, 2007. Female patient, 72 years of age, weighting 202.8 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: fistula, scleroderma renal crisis. AVASTIN dosage: 750 MG, Q3W, INTRAVENOUS. During the same period patient was treated with MITOMYCIN, XELODA, PERINDOPRIL ERBUMINE, INDAPAMIDE, SPIRONOLACTONE, PAROXETINE, DESLORATADINE. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from NETHERLANDS on Jan 27, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: epilepsy. AVASTIN dosage: unknown. Patient recovered.
Physician from UNITED KINGDOM reported AVASTIN problem on Jan 27, 2007. Male patient, 51 years of age, weighting 159.2 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, neutropenic sepsis, platelet count decreased. AVASTIN dosage: 362.5 MG, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, FRAGMIN, CYCLIZINE, METRONIDAZOLE, DIAZEPAM, CEFUROXIME. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from CANADA on Jan 27, 2007. Male patient, 38 years of age, weighting 153.9 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. AVASTIN dosage: 524 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient recovered.
Health Professional from FRANCE reported AVASTIN problem on Jan 27, 2007. Male patient, 69 years of age, weighting 207.2 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. AVASTIN dosage: 450 MG, INTRAVENOUS. During the same period patient was treated with ELOXATIN, ELVORINE. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2007. Male patient, 57 years of age, weighting 150.4 lb, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, rectal stenosis. AVASTIN dosage: 497 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, OXYCODONE, LOXONIN, NORVASC, BLOPRESS, PURSENNID, LAXOBERON. Patient was hospitalized. Patient recovered.
Physician from NETHERLANDS reported AVASTIN problem on Jan 17, 2007. Male patient, 69 years of age, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm rupture, constipation, gastric disorder, haemoglobin decreased, hypotension, shock. AVASTIN dosage: 548 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, OMEPRAZOLE, ACETAMINOPHEN, OXAZEPAM, AUGMENTIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 12/05/2006.
AVASTIN problem was reported by a Health Professional from AUSTRALIA on Jan 27, 2007. Male patient, 68 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, neuropathy, sepsis. AVASTIN dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, ATENOLOL, KARVEZIDE. Patient was hospitalized. Patient died.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 27, 2007. Female patient, 68 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: face oedema, intraocular pressure increased. AVASTIN dosage: unknown. During the same period patient was treated with EYE DROPS NOS. Patient recovered.
AVASTIN problem was reported by a Health Professional from UNITED STATES on Jan 27, 2007. Female patient, 57 years of age, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, herpes virus infection, oesophagitis, throat tightness, weight decreased. AVASTIN dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, OXYCONTIN, ZOFRAN, DURAGEISC. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Jan 18, 2007. Male patient, 63 years of age, weighting 188.9 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood pressure increased, dyspnoea, hypersomnia, mental status changes, platelet count decreased, pulmonary embolism, pyrexia, sinus tachycardia. AVASTIN dosage: 868 MG, Q2W, INTRAVENOUS. During the same period patient was treated with PROLEUKIN, LEVOFLOXACIN, RHINOCORT. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Health Professional from HONG KONG on Jan 16, 2007. Female patient, 47 years of age, weighting 102.7 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: abdominal wound dehiscence, arrhythmia, ascites, blood albumin increased, blood potassium decreased, disease progression, gastrointestinal perforation, haemoglobin decreased. AVASTIN dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, DOLOGESIC, METHADONE, PROTHIADEN, DIAMICRON, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient died on 07/31/2006.
Health Professional from NEW ZEALAND reported AVASTIN problem on Nov 21, 2006. Male patient, 68 years of age, weighting 124.1 lb, was diagnosed with colorectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: confusional state, gastrointestinal perforation, mental status changes, somnolence. AVASTIN dosage: 325 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, METOPROLOL TARTRATE, BENDROFLUAZIDE, ALLOPURINOL, LOPERAMIDE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Pharmacist from UNITED STATES on Feb 01, 2007. Male patient, 74 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. AVASTIN dosage: 15MG/KG Q21 DAYS IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, PEPCID, BENADRYL, TYLENOL, ATIVAN, DECADRON, ALOXI. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported AVASTIN problem on Feb 01, 2007. Female patient, 56 years of age, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: pneumonia, pulmonary embolism. AVASTIN dosage: 5MG/KG Q14 DAYS IV. During the same period patient was treated with FOLFIRI. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Pharmacist from UNITED STATES on Feb 01, 2007. Male patient, 70 years of age, weighting 217.8 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: blood pressure abnormal, deep vein thrombosis. AVASTIN dosage: 5MG/KG Q14D IV. During the same period patient was treated with IRINOTECAN, LEUCOVORIN CALCIUM, FLUOROURACIL, ONDANSETRON, DIOVAN. Patient recovered.
Health Professional from UNITED STATES reported AVASTIN problem on Feb 01, 2007. Male patient, weighting 179.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: oesophageal varices haemorrhage. AVASTIN dosage: 5 MG/M2 Q3 WEEKS IV DRIP. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Health Professional from on Jan 30, 2007. Female patient, weighting 126.1 lb, was diagnosed with neurological symptom and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, dehydration, hallucination, hallucination, visual, hypokalaemia, infection, syncope. AVASTIN dosage: unknown. During the same period patient was treated with LORTAB, COUMADIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEXAPRO, FLUOROURACIL, ATIVAN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported AVASTIN problem on Jan 27, 2007. Female patient, 68 years of age, weighting 201.9 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: diverticulitis. AVASTIN dosage: 680 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB. Patient recovered.
AVASTIN problem was reported by a Health Professional from UNITED STATES on Jan 17, 2007. Female patient, 53 years of age, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, splenomegaly, splenorenal shunt, varicose vein, venoocclusive liver disease. AVASTIN dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.
Physician from UNITED STATES reported AVASTIN problem on Jan 19, 2007. Male patient, 71 years of age, was diagnosed with adenocarcinoma pancreas and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: abscess, bile duct obstruction, biliary tract disorder, dilatation intrahepatic duct acquired, post procedural bile leak, procedural site reaction. AVASTIN dosage: 10 MG/KG, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, LORTAB, CREON, ERYTHROMYCIN, LOPRESSOR, MEGACE, PRILOSEC. Patient was hospitalized. Patient recovered.
AVASTIN problem was reported by a Physician from UNITED STATES on Jan 23, 2007. Female patient, 56 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea. AVASTIN dosage: unknown. During the same period patient was treated with PANITUMUMAB, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient died on 10/15/2006.
Physician from UNITED STATES reported AVASTIN problem on Jan 27, 2007. Female patient, 67 years of age, weighting 121.9 lb, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: enteritis, enterocolitis, infection, intestinal obstruction. AVASTIN dosage: 291 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, XALATAN. Patient was hospitalized. Patient recovered.
Showing 1-75 of 1647 Next >
This
drug has an active FDA Safety Alert